MJFF Access Advocate for Clinical Research Participation
Supports structured trial access advocacy in Parkinson's programs by strengthening participant pathways at sites.
The Michael J. Fox Foundation Access Advocate for Clinical Research Participation program funds clinical trial sites in the United States and Canada to implement a structured Access Advocate model aimed at improving inclusive, representative enrollment and retention in Parkinson's disease clinical trials. MJFF, founded in 2000 and having raised over $2 billion for PD research, created this program…
Funds implementation of a structured Access Advocate model at US/Canada clinical trial sites to improve inclusive, representative enrollment and retention in Parkinson's disease clinical trials.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up